Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
nubia Z80 Ultra Now Available for Global Pre-Order: Unleash Elite Gaming and Professional Photography with Snapdragon® 8 Elite Gen 5
-
Intellum and HexaLearn Partner to Deliver End-to-End, Scalable Learning and Technology Solutions
-
Shift4 Announces Third Quarter 2025 Results
-
Online Mattress Shoppers Find Greater Value and Satisfaction Than In-Store Buyers, J.D. Power Finds
-
Altice USA Changes Corporate Name and NYSE Ticker Symbol to Align with Optimum Brand
-
ConocoPhillips announces third-quarter 2025 results; increases quarterly ordinary dividend by 8% and announces preliminary 2026 guidance
-
Overland Oasis launches resupply stations for RVers, digital nomads, campers and adventure motorcyclists
-
Baker Hughes Secures Additional Order for Rio Grande LNG Expansion
-
Angel Oak Mortgage REIT, Inc. Reports Third Quarter 2025 Financial Results
-
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
-
Mark Cuban Cost Plus Drug Company Expands Access with Addition of Starjemza® (ustekinumab-hmny) to Give Patients More Power Over Prescription Costs
-
AstraZeneca's 9M and Q3 2025 Financial Results
-
Bio-Techne to Present at Upcoming Investor Conferences
-
LCI Industries to Participate in Upcoming Truist Conference
-
TIC Solutions Announces Upcoming Participation in Baird's 2025 Global Industrial Conference
-
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
-
Agora, Inc. to Report Third Quarter 2025 Financial Results on November 19, 2025
-
Tecnoglass Reports Third Quarter 2025 Results
-
The Cigna Group Appoints Dr. Amy Flaster Chief Medical Officer
-
Pow.Bio, Bühler, and ATV Technologies Announce Major Advancement in Continuous Biomanufacturing with 3,000-Liter Scale Success
-
CareCloud Reports Third Quarter 2025 Results
-
Microvast Schedules Third Quarter Earnings Call
-
Advantage Solutions Reports Third Quarter 2025 Results
-
Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update
-
Amplify ETFs Named “Best Crypto-Linked ETF Issuer 2025” by ETF Express
-
Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week
-
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
-
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
-
TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in Refractory MSS mCRC in JCO Oncology Advances
-
Lantheus Announces Leadership Transition Plan
-
Verano Announces Exclusive Partnership with Raw Garden, a Leading California Cannabis Operator, to Launch Raw Garden Branded Products in New Jersey
-
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Inventus Announces Bulk Sample Processing Underway and Provides Drill Program Update
-
C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Accipiter Biosciences Emerges from Stealth with $12.7 Million in Seed Financing to Deliver de novo Protein Therapies for Complex Diseases
-
Gogo Announces Third Quarter 2025 Results
-
LENSAR® Reports Third Quarter 2025 Results and Provides Business Update
-
Matrix Service Company Announces Award for the Balance of Plant Supporting a Large, Dual Service Full Containment Storage Tank for Delaware River Partners
-
Harvard Bioscience Announces Third Quarter 2025 Financial Results
-
Lifetime Brands, Inc. Reports Third Quarter 2025 Financial Results
-
Datadog Announces Third Quarter 2025 Financial Results
-
Entrada Therapeutics Reports Third Quarter 2025 Financial Results
-
Village Farms International Welcomes Brian Ellis as Chief Information and Technology Officer
-
WeightWatchers Announces Third Quarter 2025 Results
-
Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, “NEO-CYT”, in High-Risk, Surgically Resectable Stage
-
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
-
Electrokare Launches Groundbreaking Real-Time Electrolyte Tracking Platform to Power the Modern Performance Athlete
-
FactSet Declares Dividend
-
Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care
-
OTC Markets Group Welcomes SUN SILVER LTD. to OTCQX

